Within3 and Array have announced a strategic partnership integrating synchronous and asynchronous insights management. This partnership is driven by recognizing a market gap and the desire to offer clients a single, high-quality tech partner for comprehensive engagement solutions.

"Within3’s AI-powered insights management platform and Array’s content engagement solution provide pharma companies and agencies with strategic advantages beyond engagement: a real-time view of the market integrating advisory board feedback, social listening, and field interactions, essential for medical and commercial strategies," said Lance Hill, CEO of Within3. "The collaborative approach ensures that clients can opt for synchronous live engagement, asynchronous interactions, or a harmonious blend of both while providing comprehensive insights reporting."

The partnership's operational model leverages Within3's flexible content delivery with Array's expertise in fostering real-time engagement. The offering is expected to broaden its reach into the engagement category, offering clients a more complete and efficient solution. With a shared commitment to client satisfaction and successful program execution, Array and Within3 will facilitate meaningful interactions between healthcare professionals, patients, agencies, and pharmaceutical stakeholders by leveraging the advantages of both engagement and insights models, redefining the industry standard.

“We’re looking forward to offering this new avenue for our clients,” explains Marc Crawford, CEO of Array. “We intend to deliver a comprehensive, real-time, personalized experience with unparalleled, holistic insights.”

The partnership marks a significant step forward for clients who have worked with Within3 or Array. For healthcare professionals, patients, agencies, and pharmaceutical stakeholders, this collaboration means access to clearer, more effective engagement strategies and data-driven support that simplifies complex decision-making and enhances the impact of their work in the life science field.